Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases – The FAR-PEARL Study Report 1

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases – The FAR-PEARL Study Report 1

Kenneth CS Fong,1 Wilson Jun Jie Wong,1 Hon Seng Wong,1 Kiet Phang Ling,1 Shir-Ning Fong,2 Manoharan Shunmugam1 1OasisEye Specialists, Kuala Lumpur, Kuala Lumpur, Malaysia; 2University of Nottingham Medical School, Nottingham, NG72UH, UKCorrespondence: Kenneth CS Fong, Email Ken.fong@oasiseye.myPurp...

Full description

Saved in:
Bibliographic Details
Main Authors: Fong KC, Wong WJJ, Wong HS, Ling KP, Fong SN, Shunmugam M
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Clinical Ophthalmology
Subjects:
Polypoidal Choroidal Vasculopathy
Faricimab
Refractory Neovascular AMD
Anti-VEGF Resistance
Visual and Anatomical Outcomes
Real-World Study
Online Access:https://www.dovepress.com/switching-to-faricimab-for-polypoidal-choroidal-vasculopathy-with-real-peer-reviewed-fulltext-article-OPTH
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/switching-to-faricimab-for-polypoidal-choroidal-vasculopathy-with-real-peer-reviewed-fulltext-article-OPTH

Similar Items